ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
27.83
+0.09 (0.32%)
At close: Sep 11, 2026, 4:00 PM EDT
27.55
-0.28 (-1.01%)
After-hours: Sep 11, 2026, 7:34 PM EDT
ACADIA Pharmaceuticals Employees
As of December 31, 2025, ACADIA Pharmaceuticals had 798 total employees, including 796 full-time and 2 part-time employees. The number of employees increased by 144 or 22.02% compared to the previous year.
Employees
798
Change (1Y)
144
Growth (1Y)
22.02%
Revenue / Employee
$1,426,872
Profits / Employee
$476,797
Market Cap
4.80B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| CRISPR Therapeutics AG | 393 |
| Xenon Pharmaceuticals | 370 |
| Relay Therapeutics | 202 |
| Celcuity | 155 |
| Parabilis Medicines | 145 |
| Edgewise Therapeutics | 127 |
| Definium Therapeutics | 106 |
ACAD News
- 19 days ago - Acadia Pharmaceuticals price target raised to $38 from $37 at Deutsche Bank - TheFly
- 19 days ago - Acadia Pharmaceuticals price target raised to $28 from $27 at Morgan Stanley - TheFly
- 19 days ago - Acadia Pharmaceuticals price target raised to $40 from $39 at Citi - TheFly
- 20 days ago - Acadia Pharmaceuticals announces EC marketing authorization for Daybu - TheFly
- 20 days ago - European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union - Business Wire
- 27 days ago - Acadia Pharmaceuticals price target raised to $49 from $45 at UBS - TheFly
- 27 days ago - Acadia Pharmaceuticals price target raised to $41 from $38 at Needham - TheFly
- 4 weeks ago - ACADIA Pharmaceuticals Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts